All Roads Lead to Change: Addressing Unmet Needs in the African American MS Community
Best Practices in Improving Care Quality and Mitigating Health Disparities from the Multiple Sclerosis Association of America Working Group

Release Date: September 1, 2022
Expiration Date: March 31, 2024
Estimated Time to Complete Activity: 1.0 hour
Compatible with all modern browsers and mobile devices

Expert Working Group Members:


	Mitzi Joi Williams, MD Joi Life Wellness Group, LLC Click here for biography

	Oluwasheyi Akin Ayeni, MD Clinical Neurologist Kaiser Permanente Click here for biography

	Annette Howard, MD Medical Director MS Institute of Texas Click here for biography

	Annette Okai, MD Medical Director MS Treatment Center of Dallas Baylor University Medical Center Click here for biography

	Angala B. Borders-Robinson, DO, FACN Clinical Neurologist Noran Neurological Clinic Click here for biography

	Jacqueline Faulkner Rosenthal, MD Clinical Neurologist Shepherd Center Click here for biography

	Aljoeson Walker, MD Clinical Neurologist Medical University of South Carolina Click here for biography

	Yolanda Smith Wheeler, PhD, RNP, CPNP-AC, MSCN Assistant Professor UAB School of Nursing, The University of Alabama at Birmingham Click here for biography

	Tirisham Gyang, MD Assistant Clinical Professor University of Florida College of Medicine Click here for biography

	Sophia D. Woodson, CNP Neurology Nurse Practitioner UH Cleveland Medical Center Click here for biography

	Heidi Crayton, MD Clinical Neurologist MS Center of Greater Washington Click here for biography

	Angela Lang Chandler, MD Clinical Neurologist Baptist Neurosciences Click here for biography

Target Audience
This activity is designed to meet the educational needs of a broad audience of health care providers including neurologists, primary care providers, registered nurses, ER providers, social workers, and case managers involved in treatment and management of Black patients with MS.

Statement of Need/Program Overview
Provide content direction and recommendations for a set of multifaceted interventions to improve the knowledge and performance of MS clinicians that are currently, or, have the potential to treat African American MS patients. The anticipated result of these interventions is to better identify and detect early signs of disease progression, along with appropriate and timely therapeutic intervention for the African American MS patient population.

Educational Objectives

Identify the impact of MS in African American patients and the barriers to appropriate MS care
Apply strategies to minimize diagnostic and treatment delays in African American patients with MS
Deploy a roadmap for navigating MS care for African American patients

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, Multiple Sclerosis Association of America, and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-22-322-H01-P
Type of Activity: Knowledge

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

*Name of Working Group Members/Planners*	*Reported Financial Relationship*
Mitzi Joi Williams, MD	Consulting fees (ex. advisory boards) - Novartis, Biogen, EMD Serono, AbbVie, Genzyme, Bristol Meyers Squibb, Alexion Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus) - Novartis, Biogen, EMD Serono, AbbVie, Genzyme, Bristol Meyers Squibb, TEVA
Oluwasheyi Akin Ayeni, MD	Oluwasheyi Akin Ayeni, MD has nothing to disclose.
Annette Howard, MD	Consulting fees (ex.advisory boards): EMD Serono, Bristol Myers Squibb, Sanofi Genzyme Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): EMD Serono, Bristol Myers Squibb, Sanofi Genzyme
Annette Okai, MD	Consulting fees (ex.advisory boards): Sanofi Genzyme, Genentech, Biogen, Novartis, EMD Serono Contracted Research: Sanofi Genzyme, Genentech, Biogen
Angala B. Borders-Robinson, DO, FACN	Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): Novartis, Sanofi Genzyme, Genentech
Jacqueline Faulkner Rosenthal, MD	Consulting fees (ex.advisory boards): Genentech
Aljoeson Walker, MD	Consulting fees (ex.advisory boards): Biogen Ownership Interest less than 5%: Pfizer
Yolanda Smith Wheeler, PhD, RNP, CPNP-AC, MSCN	Salary: National MS Society Consulting fees (ex.advisory boards): African American Advisory Board for the MSAA; Bafiertan Nurse Virtual Advisory Board for Banner Life Sciences
Tirisham Gyang, MD	Consulting fees (ex.advisory boards):EMD Serono, Genentech Contracted Research: Sanofi
Sophia D. Woodson, CNP	Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): Biogen, Genentech, Novartis
Heidi Crayton, MD	Consulting fees (ex.advisory boards): Biogen, Bristol Myers Squibb, EMD Serono, Roche Contracted Research: Biogen, Novartis, Roche
Angela Lang Chandler, MD	Consulting fees (ex.advisory boards) – National MS Society, SK Life Science Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): SK Life Sciences, Sanofi Genzyme, Teva

The PIM planners and managers have nothing to disclose.
The MSAA planners and managers have nothing to disclose.
The Impact Education, LLC® planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period of accreditation participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) and complete the evaluation form. Upon completion of the full CME/CE activity, a certificate will be made available immediately to download and print.

MEDIA
Internet

FEE INFORMATION
There is no fee for this educational activity.